Close Menu

NEW YORK (360Dx) – Quidel today announced it has amended its previously announced acquisition of Alere's Triage B-type naturietic peptide assay business to include Quidel's direct commercial responsibility for the assays run on Beckman Coulter analyzers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.